Faricimab - Wet age-related macular degeneration
You are here : Home > Formulary Search > Faricimab - Wet age-related macular degeneration
Status 1
- Intravitreal injection
Documentation
PAD Profile
Committee Recommendations (1)
The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) has agreed the use of faricimab as a treatment option for treating wet age-related macular degeneration in line with NICE TA800.
Faricimab will be given a RED traffic light status. Prescribing will be by hospital specialists only, in line with NICE TA800.
Primary care prescribers should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient's medication.
Other Indications
Below are listed other indications that Faricimab is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Wet age-related macular degeneration.